JP2020527036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527036A5 JP2020527036A5 JP2019572845A JP2019572845A JP2020527036A5 JP 2020527036 A5 JP2020527036 A5 JP 2020527036A5 JP 2019572845 A JP2019572845 A JP 2019572845A JP 2019572845 A JP2019572845 A JP 2019572845A JP 2020527036 A5 JP2020527036 A5 JP 2020527036A5
- Authority
- JP
- Japan
- Prior art keywords
- cell receptor
- cell
- molecule
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023020851A JP7515209B2 (ja) | 2017-03-07 | 2023-02-14 | 癌免疫療法用ｍｒ１制限ｔ細胞受容体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17159754 | 2017-03-07 | ||
| EP17159754.5 | 2017-03-07 | ||
| EP17179309.4 | 2017-07-03 | ||
| EP17179309 | 2017-07-03 | ||
| PCT/EP2018/055620 WO2018162563A1 (en) | 2017-03-07 | 2018-03-07 | Mr1 restricted t cell receptors for cancer immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023020851A Division JP7515209B2 (ja) | 2017-03-07 | 2023-02-14 | 癌免疫療法用ｍｒ１制限ｔ細胞受容体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527036A JP2020527036A (ja) | 2020-09-03 |
| JP2020527036A5 true JP2020527036A5 (https=) | 2021-02-18 |
| JP7233103B2 JP7233103B2 (ja) | 2023-03-06 |
Family
ID=61563412
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572845A Active JP7233103B2 (ja) | 2017-03-07 | 2018-03-07 | 癌免疫療法用ｍｒ１制限ｔ細胞受容体 |
| JP2023020851A Active JP7515209B2 (ja) | 2017-03-07 | 2023-02-14 | 癌免疫療法用ｍｒ１制限ｔ細胞受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023020851A Active JP7515209B2 (ja) | 2017-03-07 | 2023-02-14 | 癌免疫療法用ｍｒ１制限ｔ細胞受容体 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP4273233A3 (https=) |
| JP (2) | JP7233103B2 (https=) |
| KR (1) | KR20190126332A (https=) |
| CN (1) | CN110462024B (https=) |
| AU (1) | AU2018231405B2 (https=) |
| CA (1) | CA3054758A1 (https=) |
| IL (1) | IL268813A (https=) |
| WO (1) | WO2018162563A1 (https=) |
| ZA (1) | ZA201905579B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019525898A (ja) * | 2016-06-10 | 2019-09-12 | ガデタ・ベー・フェー | ヒト白血球抗原拘束ガンマデルタｔ細胞受容体及びその使用方法 |
| JP7486953B2 (ja) | 2017-05-18 | 2024-05-20 | ユーエムセー・ユトレヒト・ホールディング・ベー・フェー | 細胞標的化療法のための組成物および方法 |
| GB201717578D0 (en) | 2017-10-26 | 2017-12-13 | Univ College Cardiff Consultants Ltd | Novel T-cell receptor |
| CN112236447B (zh) * | 2018-04-19 | 2023-10-20 | 得克萨斯州大学系统董事会 | 具有mage-b2特异性的t细胞受体及其用途 |
| JP2022500038A (ja) * | 2018-09-12 | 2022-01-04 | ウニヴェルズィテート バーゼル | 癌免疫療法用ｍｒ１制限ｔ細胞受容体 |
| WO2020118094A1 (en) * | 2018-12-06 | 2020-06-11 | Guangdong Tcrcure Biopharma Technology Co., Ltd. | Combinational tcr-t cell therapy targeting tumor antigens, tgf-beta, and immune checkpoints |
| CN113621070A (zh) | 2020-05-06 | 2021-11-09 | 华夏英泰（北京）生物技术有限公司 | 一种t细胞抗原受体、其多聚体复合物及其制备方法和应用 |
| WO2022118043A1 (en) | 2020-12-03 | 2022-06-09 | Enara Bio Limited | Novel protein-ligand complex |
| WO2022248881A1 (en) | 2021-05-28 | 2022-12-01 | Enara Bio Limited | Novel protein-ligand complex |
| KR20230088292A (ko) * | 2021-12-10 | 2023-06-19 | 주식회사 유틸렉스 | MR1 제한적 Panck T 세포 및 이의 제조방법 |
| WO2023148494A1 (en) * | 2022-02-03 | 2023-08-10 | University College Cardiff Consultants Limited | Novel t-cell receptor |
| CN119587561B (zh) * | 2024-12-09 | 2025-11-28 | 新乡医学院 | THP在制备增强Vγ9Vδ2 T细胞抗肿瘤疗效的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2089229C (en) * | 1992-02-14 | 2010-04-13 | Alejandro A. Aruffo | Cd40cr receptor and ligands therefor |
| US7829289B2 (en) * | 2002-05-14 | 2010-11-09 | Institut National De La Sante Et De Recherche Medicale | T cell subpopulation regulating gut immunity |
| JP6126804B2 (ja) * | 2012-07-25 | 2017-05-10 | 国立大学法人富山大学 | Ｔ細胞受容体のクローニング方法 |
| WO2014160030A2 (en) * | 2013-03-13 | 2014-10-02 | Health Research, Inc. | Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen |
| WO2015149130A1 (en) * | 2014-04-01 | 2015-10-08 | The University Of Queensland | Immunological reagents and uses therefor |
-
2018
- 2018-03-07 WO PCT/EP2018/055620 patent/WO2018162563A1/en not_active Ceased
- 2018-03-07 KR KR1020197027180A patent/KR20190126332A/ko active Pending
- 2018-03-07 JP JP2019572845A patent/JP7233103B2/ja active Active
- 2018-03-07 AU AU2018231405A patent/AU2018231405B2/en active Active
- 2018-03-07 EP EP23181086.2A patent/EP4273233A3/en not_active Withdrawn
- 2018-03-07 EP EP18708695.4A patent/EP3592839B1/en active Active
- 2018-03-07 CN CN201880016990.4A patent/CN110462024B/zh active Active
- 2018-03-07 CA CA3054758A patent/CA3054758A1/en active Pending
-
2019
- 2019-08-21 IL IL26881319A patent/IL268813A/en unknown
- 2019-08-23 ZA ZA2019/05579A patent/ZA201905579B/en unknown
-
2023
- 2023-02-14 JP JP2023020851A patent/JP7515209B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527036A5 (https=) | ||
| JP5934897B2 (ja) | Ｔ細胞レセプターβ鎖遺伝子及びα鎖遺伝子 | |
| RU2722696C2 (ru) | Библиотеки tcr | |
| Robbins et al. | Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions | |
| CN116731156A (zh) | 用于癌症免疫治疗的转染t细胞和t细胞受体 | |
| CN109111528B (zh) | 以msln为靶点的嵌合抗原受体 | |
| JP2021535900A5 (https=) | ||
| WO2022033057A1 (zh) | 一种基于单域抗体的bcma嵌合抗原受体及其应用 | |
| CN117186228B (zh) | 包含长cdr3序列的抗人bcma纳米抗体的双特异性抗体及应用 | |
| JP2023500318A (ja) | 細胞選択および／または細胞刺激デバイスならびに使用方法 | |
| JP2021528046A5 (https=) | ||
| CN119490589A (zh) | 一种靶向Nectin-4的纳米抗体、嵌合抗原受体CAR及应用 | |
| JP2021522779A5 (https=) | ||
| CN111848818A (zh) | 一种增强型免疫细胞及其应用 | |
| CN111808200A (zh) | Cd19和cd22双靶点嵌合抗原受体及其应用 | |
| CN117069842B (zh) | 具有特定等电点的抗人bcma纳米抗体及car-t和应用 | |
| US20230181641A1 (en) | Process for producing donor-batched cells expressing a recombinant receptor | |
| TW202140539A (zh) | 一種辨識ａｆｐ抗原短鏈胜肽的ｔ細胞受體及其編碼序列 | |
| CN114163538B (zh) | 同时靶向gpc3和cd276的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用 | |
| CN113072635A (zh) | 一种识别hpv抗原的t细胞受体及其编码序列 | |
| CN113072636B (zh) | 一种识别afp的t细胞受体及其编码序列 | |
| CN113321725B (zh) | 一种识别afp的t细胞受体 | |
| CN119613563A (zh) | 编码car的核酸分子和含其的载体、car、含car的免疫细胞及其制造方法和含该细胞的医药组合物及提升细胞损伤活性的方法 | |
| CN113999320B (zh) | 以cd28和4-1bb为共刺激结构域的靶向cd276的嵌合抗原受体及其应用 | |
| CN109400696A (zh) | 一种识别prame抗原短肽的tcr |